Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap204.51M
Enterprise Value118.17M
Trailing P/E18.05
Forward P/E21.90
UTMD
(NASDAQ)Utah Medical Products, Inc.
$63.12-- (--)
Loading... - Market loading
Utah Medical Products (UTMD) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)5.29
Forward Price/Sales5.62
Price/Book (mrq)1.71
Price/Tangible Book (mrq)2.28
Price/FCF (ttm)18.60
Price/OCF (ttm)18.16
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue3.07
EV/Earnings10.47
EV/EBITDA7.69
EV/EBIT9.68
EV/FCF10.79
Stock Price
Current price, 52-week range, and moving averages
Current Price$63.12
1-Day Change1.42%
52-Week High$68.71
52-Week Low$51.26
52-Week Change12.27%
YTD Change11.27%
1-Year Change12.71%
50-Day MA$63.96
200-Day MA$59.78
Avg Volume (30 day)9.84K
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding3.24M
Book Value per Share$36.81
Net Cash per Share$26.47
FCF per Share$3.38
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin55.73%
EBITDA Margin (ttm)39.91%
EBIT Margin (ttm)31.68%
Operating Margin (ttm)30.42%
Pretax Margin (ttm)36.63%
Profit Margin (ttm)29.30%
FCF Margin (ttm)28.44%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)9.46%
Return on Assets (ttm)9.21%
Return on Invested Capital (ttm)28.93%
Return on Capital Employed (ttm)10.17%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue38.52M
Gross Profit21.47M
Operating Income11.72M
Pretax Income14.11M
Net Income11.29M
EBITDA15.37M
EBIT12.20M
Diluted EPS$3.53
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow11.21M
Capital Expenditures262.00K
Free Cash Flow10.95M
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth-5.83%
Dividend Growth1.65%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)122.54M
Cash & Securities (mrq)85.76M
Net Cash (mrq)85.76M
Net Cash per Share$26.47
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)225.00K
Working Capital (mrq)95.14M
Total Equity (mrq)119.27M
Book Value per Share$36.81
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)37.62
Quick Ratio (mrq)34.57
Debt/Equity (mrq)0.00
Debt/EBITDA (ttm)0.01
Debt/FCF (ttm)0.02
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$1.23
Dividend Yield1.96%
Payout Ratio (Earnings)34.86%
Payout Ratio (FCF)36.38%
Dividend Growth (YoY)1.65%
Ex-Dividend DateMar 17, 2026
Pay DateApr 3, 2026
Dividend FrequencyQuarterly
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield5.54%
FCF Yield5.38%
Buyback Yield0.00%
Total Shareholder Yield1.96%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score38.90
Piotroski F-Score3/9
Dividend Score55.47
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Graham Number$54.06
Graham Upside/Downside-14.01%
Frequently Asked Questions About Utah Medical Products Statistics
What are the key financial metrics for UTMD?
Utah Medical Products, Inc. (UTMD) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is UTMD's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Utah Medical Products is overvalued or undervalued.
How do I read UTMD's profitability ratios?
Utah Medical Products's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do UTMD's debt ratios indicate?
The financial health section shows Utah Medical Products's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is UTMD's dividend analysis?
The dividend section covers Utah Medical Products's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.